Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Tools & Techniques Omics, Cancer

A Microbial Map to Cancer

We enjoy a symbiotic relationship with the trillions of microbes that inhabit our bodies. We provide them with a home and food; they assist in digestion, metabolism, and infection protection. But what if they have even more to offer? Recent research reveals that detectable changes in our gut microbiota may give us the opportunity to detect early-stage cancer.

Researchers from the European Molecular Biology Laboratory (EMBL) and the University of Trento used machine learning to perform a meta-analysis of eight metagenomic studies of colorectal cancer (1). Their goal? To identify microbial signatures distinct to cancer. “We validated these signatures in early cancer stages and in multiple studies, so they can serve as the basis for future noninvasive cancer screening,” explained EMBL’s Georg Zeller in a press release (2). Co-author Nicola Segata added, “We not only established a panel of gut microbes associated with colorectal cancer across populations, but also found signatures in microbial metabolism that have similar predictive power.”

These signatures not only offer the potential to spot cancer using microbial signatures, they may also allow scientists to understand how gut microbes can contribute causally to the development of disease. Ultimately, Zeller says, the work may even lead to a better understanding of how we can modulate the microbiome to prevent cancer. “But that’s very difficult!”

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Translational Scientist site. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

  1. J Wirbel et al., “Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer”, Nat Med, 25, 679 (2019). PMID: 30936547.
  2. EMBL, “Global microbial signatures for colorectal cancer established” (2019). Available at: bit.ly/2HIjg1X. Accessed May 30, 2019.

About the Author

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register